• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

HPV

A map of Texas and surrounding states
MedTech

BD to study HPV self-collection in underserved Texas communities

BD’s HPV test received an FDA approval in May, alongside a test developed by Roche, that allows women to skip the traditional Pap smear exam.
Conor Hale Nov 21, 2024 10:45am
HPV

GSK drops ph. 2 HPV vaccine over lack of best-in-class potential

Jul 31, 2024 8:06am
OB GYN office gynecologist

FDA approves self-collection screening for HPV, cervical cancer

May 15, 2024 11:03am
arrow miss target fail attempt try

Barinthus HPV drug doesn't prove efficacy

Apr 19, 2024 9:50am
HPV

Antiva bags $53M series E to finance future HPV trials

Apr 27, 2023 7:27am
photo of two people shaking hands one of which has red nail polish on

Merck KGaA hands over IL-12 cancer med for up to $121M

Jan 3, 2023 2:17pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings